Description
Thermo Fisher Scientific: What Is Their Long-Term Growth Strategy Towards Market Share Expansion?
Thermo Fisher Scientific posted a strong start to the year, with the first-quarter revenue reaching $10.34 billion and an increase of 2% year-over-year in adjusted EPS, to $5.11 per share. The robust financial performance was primarily driven by strong operational discipline, superior commercial execution, and its effective growth strategy. The company managed to beat their expectations which is reflected in the raised guidance, setting the stage for strong performance in 2024.
Our Report Structure:
⦁ Company Overview
⦁ Investment Thesis
⦁ Key Drivers
⦁ Historical Quarterly Statement Analysis – Income Statement & Cash Flows
⦁ Historical Quarterly Balance Sheet Analysis
⦁ Historical Annual Financial Statement Analysis
⦁ Analysis Of Key Financial Ratios
⦁ Financial Forecasts For 3 Years
⦁ Forecasting The Capital Structure & Net Debt
⦁ Discounted Cash Flow Valuation
⦁ Trading Multiples
⦁ Key Risks
⦁ Disclosures
Want unlimited access to our reports? Purchase our $99 annual subscription!
